All news articles for November 2021

Pic:getty/tinnakornjurruang

Chinook Therapeutics creates JV for kidney disease therapies in China

By Rachel Arthur

Chinook Therapeutics, Inc. has announced the formation of SanReno Therapeutics - a joint venture with an investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners China - to develop, manufacture and commercialize kidney disease...

© GettyImages/CiydemImages

Ncardia secures $60m to expand iPSC platform

By Jane Byrne

Ncardia, a human-induced pluripotent stem cell-based (iPSC) technology company, has secured more than US$60m in capital through a strategic partnership with Kiniciti, a US based investor with a focus on the global cell and gene therapy ecosystem.

Pic:getty/tosheo

EU nears decision on Novavax COVID-19 vaccine

By Rachel Arthur

The European Medicines Agency (EMA) could issue an opinion on Novavax’ Conditional Marketing Authorization for its COVID-19 vaccine ‘within weeks’.

Sartolab filtration units

Sartorius launches redesigned filtration unit

By Ben Hargreaves

The vacuum filtration units are suitable for lab-based research in low volumes, with the company stating the update improves speed, capacity, and stability.

Pic:getty/PMimages

Johnson & Johnson to spin off consumer health business

By Rachel Arthur

Johnson & Johnson has announced its intent to separate its Consumer Health business into a new publicly traded company: allowing J&J to put a sharpened focus on pharmaceuticals and medical devices.

© GettyImages/VectorFusionArt

Special Edition: BioPharma Hubs

Dublin set to get a life sciences incubation and acceleration cluster

By Jane Byrne

A new specialized lab, office and collaboration space for over 100 life science and health technology professionals, entrepreneurs, and researchers was recently announced for The Campus, Cherrywood in South Dublin, Ireland.